Pharmacolog i Uppsala AB (publ) develops systems and solutions for use of intravenous drugs in Sweden. More Details
Earnings have declined by 17.1% per year over past 5 years
Has less than 1 year of cash runway
Makes less than USD$1m in revenue (SEK884K)
Does not have a meaningful market cap (SEK49M)
Mediocre balance sheet with weak fundamentals.
Search for a company to compare.